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Abstract
Background: Acute lung injury (ALI) is a major factor determining morbidity following burns and inhalational injury. In
experimental models, factors potentially contributing to ALI risk include inhalation of toxins directly causing cell damage;
inflammation; and infection. However, few studies have been done in humans.
Methods: We carried out a prospective observational study of patients admitted to the NC Jaycees Burn Center who were
intubated and on mechanical ventilation for burns and suspected inhalational injury. Subjects were enrolled over an 8-
month period and followed till discharge or death. Serial bronchial washings from clinically-indicated bronchoscopies were
collected and analyzed for markers of cell injury and inflammation. These markers were compared with clinical markers of
ALI.
Results: Forty-three consecutive patients were studied, with a spectrum of burn and inhalation injury severity. Visible soot
at initial bronchoscopy and gram negative bacteria in the lower respiratory tract were associated with ALI in univariate
analyses. Subsequent multivariate analysis also controlled for % body surface area burns, infection, and inhalation severity.
Elevated IL-10 and reduced IL-12p70 in bronchial washings were statistically significantly associated with ALI.
Conclusions: Independently of several factors including initial inhalational injury severity, infection, and extent of surface
burns, high early levels of IL-10 and low levels of IL-12p70 in the central airways are associated with ALI in patients intubated
after acute burn/inhalation injury. Lower airway secretions can be collected serially in critically ill burn/inhalation injury
patients and may yield important clues to specific pathophysiologic pathways.
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Introduction
Acute lung injury (ALI) and acute respiratory distress syndrome
(ARDS) occur in a substantial proportion of patients following
burns and inhalational injury, and are major factors associated
with morbidity and mortality. Risk factors for lung injury include
the inhalation of products of incomplete combustion containing a
variety of toxins and particulate matter, direct cell damage,
inflammation, infection, edema, and immunologic changes due to
burn injury [1–3]. Animal models have identified multiple factors
that contribute to lung injury and edema after toxic inhalations,
including neuropeptide and bronchial artery blood flow [4].
Studies from our own research group suggest that surface burns
affect systemic immunity and expression of toll-like receptors [5,6].
However, few studies have attempted to explore pathophysiologic
and host defense factors directly in humans.
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Current therapy for inhalational injury and its pulmonary
complications is supportive and focused on mechanical ventilation
strategies, overcoming airway obstruction, and prevention or
treatment of pneumonia [7,8]. Serial bronchoscopies and airway
washings for clearance of soot, debris and secretions are part of
supportive care [9–11]. This clinical practice represents an
opportunity to obtain lower airway secretions from patients for
investigation of the relationships among mediators and clinical
outcomes of interest.
We established a repository of bronchoscopic samples for
analysis of airway mediators and their relationships with clinical
outcomes. In an initial cohort of patients, we measured levels of
selected mediators of inflammation, immunity, and tissue damage
and repair. Our goal was to examine whether mediator profiles
early after inhalational injury could be predictive of clinical
outcomes, and if these observations could be used to develop
discrete hypotheses regarding the mechanisms by which burn and
inhalational injury modulate airway innate immunity. We here
report data suggesting that specific airway cytokine patterns
(increased IL-10 and decreased IL-12) in the first several days after




We carried out a single-center, prospective observational study
of intubated patients with burns and/or suspected inhalation
injury admitted to the North Carolina Jaycees Burn Center at the
University of North Carolina Hospital at Chapel Hill, over an 8-
month period. Patients were treated and underwent bronchosco-
pies under a standardized clinical protocol as described below. For
study purposes patients were followed from the time of admission
until discharge. All patients underwent at least one bronchoscopy
soon after admission per clinical protocol. Since indications for
subsequent bronchoscopies were determined by individual clinical
factors, the total number and timing of bronchoscopies varied
among patients studied.
For the research protocol, patients were included if they were
intubated and mechanically ventilated for known or suspected
inhalational injury. Clinical data including demographics, type of
injury, and percent total body surface area burned were collected
at admission. Additional clinical data including ventilator settings,
appearance of the airway (see below), arterial blood gases,
radiographic changes, and culture results were recorded during
the subsequent clinical course at the time of each bronchoscopy.
After use of bronchial washings for clinical care purposes, any
leftover material was processed for the research protocol and
stored for mediator assays as described below. We classified patient
samples and clinical data into early, which we defined as ,72 hr.
after injury, versus ‘‘later’’ time points, which we defined as any
time point greater than 72 hours post injury and less than 14 days
post injury. Levels of early mediators measured in bronchial
washings were compared with the lowest PaO2/FiO2 ratio
measured during the first 14 days post injury, as a quantitative
marker of lung injury. PaO2/FiO2 less than 200 was a marker of
more severe lung injury compared to PaO2/FiO2 ratios greater
than 200 which indicated less severe lung injury. Study sample size
was per convenience, and limited to consecutive eligible patients
admitted and consenting to participate during a period of pilot
funding.
Since the bronchoscopic samples used for the research would
otherwise be discarded, the samples were collected and processed,
but not stored in the repository until informed consent was
obtained from the patient’s legal authorized representative (LAR).
Subjects who improved subsequently were given the opportunity
to confirm or deny the LAR’s informed consent. This study was
approved by the UNC Biomedical Institutional Review Board.
Clinical protocol for respiratory care of patients with
suspected inhalation injury
All patients with suspected inhalation injury were automatically
placed on the VDR-4H (Percussionaire Corporation, Sandpoint,
ID) high-frequency percussive ventilator (HFPV) upon arrival to
the burn center and stabilized on ventilator settings in accordance
with low-tidal volume protective ventilation strategy.
All intubated patients with suspected inhalation injury under-
went bronchoscopic evaluation within 24 hours of admission for
the presence of inhalation injury. The bronchoscope was inserted
into the endotracheal tube and the central airways inspected
visually and graded for the presence of soot (minimum = 1,
moderate = 2, severe = 3), mucosa inflammation (no = 0, yes = 1),
mucosal sloughing (no = 0, yes = 1) and secretions (minimum = 1,
moderate = 2, severe = 3). A total inhalation injury score (range 2–
8) was calculated by adding the score for these four parameters at
each bronchoscopy. After that, bronchial washings were per-
formed in which 20 mL sterile saline lavage fluid was instilled and
suctioned back from each mainstem bronchus, then collected in a
suction trap. Bronchial washings were sent for culture as needed
per clinical situation.
After the initial bronchoscopic evaluation, patients underwent
subsequent bronchoscopies based on clinical necessity, e.g., daily
until all traces of visible soot were removed; as part of assessment
of increased secretions or change in radiographic findings; before
changing to another mode of ventilation; or as part of fever or
elevated white blood cell evaluation. Ventilator management of
these patients was done in collaboration between the surgical staff
and respiratory therapists.
Processing of bronchial washings and mediator assays
Bronchial washing specimens were transported on ice and
processed within several hours of specimen collection. Briefly,
samples were centrifuged at 300 g and aliquots of the resultant
cell-free supernatant were stored at 280uC for subsequent
mediator measurements. Neuropeptidase inhibitor was added to
one aliquot from each specimen prior to freezing, for subsequent
neuropeptide assays. A limited number of mediators was selected
for assay in bronchial washings, as roughly representative of
inflammatory (tumor necrosis factor alpha (TNF-a), interleukin-1
beta (IL-1b), IL-6, IL-8), immune (IL-10, IL-12p70, interferon
gamma (IFNc)), tissue damage and repair (double-stranded
deoxyribonucleic acid (dsDNA), transforming growth factor beta-
1 (TGF-b1)), and neuropeptide (substance P, calcitonin gene-
related peptide (CGRP)) responses. Cytokines (IL-1b; IL-6; IL-8,
IL-10; IL-12 p70; IFNc; TNF-a) were measured using a multiplex
ELISA platform (MesoScale Discovery, Gaithersburg, MD). TGF-
b1 was measured using a commercial ELISA kit (R & D Systems,
Minneapolis, MN). dsDNA was quantified using QuantItTM
PicoGreenH dsDNA Assay Kit (InvitrogenTM Ltd, Eugene, OR),
a fluorescent nucleic acid stain. Substance P (R & D Systems,
Minneapolis, MN) and CGRP (Peninsula Laboratories, San
Carlos, CA) were measured using commercial ELISA kits. All
assays were run according to manufacturer’s instructions.
Statistics
Subjects underwent 1–3 bronchoscopies during the initial 72 hr.
post injury. To reduce the data to a single point per mediator and
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patient, if multiple samples were generated for a patient during the
first 72 hr., the mediator data were averaged. The association
between the average levels of mediators in bronchial washings
collected in the first 72 hours, and the clinical outcome, as
represented as the lowest PaO2/FiO2 ratio observed during the
initial14 days post injury, was then evaluated using a multivariate
regression model where confounding covariates like bacterial
lower respiratory infection, visual severity of initial injury, gender,
and ethnicity are included in the model. Specifically, we fitted the
following regression model:
PaO2=FiO2~b0zb1I not infectedð Þzb2I non-severe burnð Þ
zb3Injury scorezb4TestzB5I Femaleð Þzb6Agezb7BMI
zb8I Blackð Þzb9I Caucasianð Þzerror
where Test was one of the measured mediators. All of the test
variables were standardized so that they all had a mean of 0 and a
standard deviation of 1.
Results
Patient Characteristics: During the 8-month study period, 783
patients were admitted to the Burn Center for treatment of
injuries. Of these, 64 were intubated and eligible for study under
our protocol. Six patients were not approached for participation
because their admission was too brief; 5 declined to participate; 3
were non-English speaking; and 7 died before consent could be
obtained. Thus, 43 consented to participate. One enrolled patient
was excluded from the data analysis due to lack of specimens
obtained during the first 72 hours post-injury, and another 2 did
not have sufficient material left for analysis, after clinical use of
specimens. Thus, there were a total of 40 patients who comprise
our study population.
Demographic data for the 40 patients studied are shown in
Table 1. Cutaneous burn size ranged from 0–85% total body
surface area (TBSA), with a mean of 18% TBSA. The plurality of
patients suffered their injuries due to flame injuries (40%), followed
by house fires (30%) and explosions (25%). Our study population
demographics were similar to those published trends in the 2011
Summary Report of the National Burn Repository, American
Burn Association (http://128.121.65.211/2011 NBRAnnualRe-
port.pdf). All demographic parameters were similar between the
subgroups who had PaO2/FiO2 ,200, and PaO2/FiO2 $200.
After injury, length of hospital stay ranged from 2–136 days,
(mean 39 days). The number of days on the ventilator was variable
and averaged 28 days; this time was determined not only by the
severity of inhalation injury or pulmonary status, but also by %
TBSA and co-morbid conditions. Mortality was 15% for the study
population. Mean %TBSA burns, number of days in hospital, and
number of days on ventilator were all slightly higher in the
subgroups who had PaO2/FiO2 ,200, vs. PaO2/FiO2 $200.
Percent mortality was slightly lower in the PaO2/FiO2 ,200
subgroup (Table 1).
While mean % neutrophils in bronchial washings during the
first 72 hr. post injury was higher in the group with PaO2/FiO2
,200 (84.563.6%) than in the group with PaO2/FiO2 .200
(78.763.2%), the difference was not statistically significant
(P = 0.23). In initial univariate analyses, % TBSA burns did not
appear to predict PaO2/FiO2. Initial airway injury score via
bronchoscopic grading was on average higher in the group with
PaO2/FiO2 ,200, but this difference was not statistically
significant (P = 0.11; Figure 1). While having any bacterial
respiratory infection (defined as at least one positive lower
respiratory culture for bacterial pathogens within the first 14 days
post injury) was associated with only slightly lower PaO2/FiO2
than if there was no infection (233652 vs. 273624), the subgroup
in which a gram negative bacterial pathogen was isolated had a
mean PaO2/FiO2 of only 144614 (P,0.001 vs. no infection).
(Fig. 2). These parameters were included as covariates in the
multivariate model. The bacterial organisms that were identified
from BALF in the first 14 days after injury include: gram-positive
organisms, e.g., Oxacillin resistant Staphylococcus aureus and gram
negative organisms, e.g., Haemophilus influenza and Klebsiella
pneumonia (See Table 2). This study was not designed to determine
an association between inflammatory mediators, lung injury and
infection, but will be explored in future studies.






N 24 16 40
Age (yrs) 46.464.0 44.464.9 45.663.1
Gender (% female) 5/24 (21%) 4/16 (25%) 9/40 (23%)
BMI 27.961.7 28.362.3 28.161.3
% TBSA 17.763.6 18.664.3 18.362.9
Bronchoscopies* 2.660.3 3.860.6 3.160.3
Abnormal chest radiograph** 19/24 (79%) 15/16 (94%) 34/40 (85%)
Days on ventilator 23.665.0 34.168.0 27.864.4
Days in hospital 31.564.8 50.967.2 39.364.3
Mortality 4/24 (17%) 2/16 (13%) 6/40 (15%)
*Within 1st 14 days after injury.
**Read by radiologist as having either infiltrates, edema, or atelectasis.
doi:10.1371/journal.pone.0064250.t001
Figure 1. Comparison of airway injury score (graded for soot,
inflammation, epithelial sloughing and secretions at ,72 hr
post injury), between patients with the lowest PaO2/FiO2 ratios
during the first 2 weeks post injury (PaO2/FiO2) of ,200
(N = 16), and patients with PaO2/FiO2 $200 (N = 24). Bars
represent mean 6 SE. P = 0.11, t-test with Welch’s correction for
unequal variances.
doi:10.1371/journal.pone.0064250.g001
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Relationship of soluble mediators in bronchial washings
to ALI
Table 3 shows levels of the mediators we measured in bronchial
secretions, in patients with lower PaO2/FiO2 vs. higher PaO2/
FiO2. In the multivariate regression model, each measured soluble
factor in early mainstem bronchial washings was tested as a
predictor of PaO2/FiO2. Bacterial respiratory infection during the
first 14 days, % TBSA burn, initial airway injury score, age,
gender and race were treated as potential confounders in the
model.
Substance P was undetectable in most specimens. IL-1b, IL-6,
IL-8, TNF-a, and CGRP were readily measureable but were not
significant predictors of PaO2/FiO2. IFNc (P = 0.051), TGF-b1
(P = 0.10), and dsDNA (P = 0.11) were also not statistically
significant predictors of PaO2/FiO2 though their P values in the
multivariate model were closer to the predetermined level of
significance. For descriptive purposes, the mean 6 SE data for
these mediators are shown in Table 2, for the patient groups with
PaO2/FiO2 ,200 vs. PaO2/FiO2 $200.
IL-12p70 and IL-10 were significant (P,.05) predictors of
PaO2/FiO2. For descriptive purposes these factors are shown in
relation to the lowest PaO2/FiO2 (.200, indicative of less severe
lung injury versus ,200, indicative of more severe lung injury)
observed in the first 14 days after injury in Figures 3 and 4. For IL-
12p70, higher concentration was associated with greater PaO2/
FiO2 ratios, indicating less severe lung injury. Greater IL-10 levels
were associated with lower PaO2/FiO2 ratios or more severe lung
injury. Because dilution of native airway secretions by lavage fluid
was not accounted for in the preceding analyses, we also calculated
the ratio of early IL-10 to early IL-12p70 for each patient and
compared the PaO2/FiO2 ,200 subgroup to the PaO2/FiO2
.200 subgroup. The IL-10/IL-12p70 ratio was significantly
higher for the PaO2/FiO2 ,200 subgroup (8.162.7, vs. 2.860.5;
P = 0.028; Figure 5).
Discussion
In a prospectively studied cohort of endotracheally intubated or
tracheotomized inpatients with burn and inhalational injuries, we
observed that early cytokine patterns in airway secretions may be
predictive of the severity of lung injury. In particular, elevated IL-
10 and decreased IL-12p70 may be associated with progression to
more severe lung injury, even after accounting for the potential
confounders of burn severity, bacterial lower respiratory infection,
and the severity of initial injury in the large central airways.
Elevated levels of IFNc, TGF-b1, and dsDNA also tended toward
association with more severe lung injury, but were not statistically
significant in our multivariate model.
For many years, the immune response to serious injury has been
defined as an initial pro-inflammatory response that is quickly
followed by a systemic inflammatory response syndrome (SIRS),
which if uncontrolled, results in early multiple organ dysfunction
syndrome (MODS) and, ultimately death In most patients
however, after a period of relative stability, a compensatory anti-
inflammatory response syndrome (CARS) develops with associated
immunosuppression and increased risk of infection that if
uncontrolled, can also result in MODS and death. The controlling
mechanisms for initiating and sustaining the development of SIRS
and CARS have not been fully elucidated and attempts to
modulate either response with cytokine therapy have largely been
unsuccessful [12], except in very specific and controlled animal
models of burn injury and other models of trauma [13–19]. The
failure of this intervention may be because the immune phenotype
after injury has not been fully defined, especially late after injury
when immune failure and subsequent infection, sepsis, MODS
and ALI are most likely. We, and others, have attempted to define
the cytokine response in mouse models and humans and it is clear
that SIRS to CARS progression is overly simplistic, with dynamic
alterations in specific cell populations and specific cytokine
responses at different physiologic sites. We argue that the human
lung represents a crucial site to investigate the immune response as
a common cause of death after trauma is bacterial pneumonia.
Investigation of perturbations of the IL-10/IL-12 axis provides the
foundation for further studies to define the cellular and molecular
mechanisms. These studies will lead to specific immunotherapies
that will reduce length of stay and improve survival after
inhalation injury.
Ours is one of several recent studies to describe mediator
concentrations in bronchial washings in burn/inhalational injury
patients. Kurzius-Spencer et al. [20] measured cytokines in serial
tracheal aspirates during the first 72 hr. post injury in a smaller
series of intubated smoke inhalation victims, and reported a direct
Figure 2. Comparison of the lowest PaO2/FiO2 ratios during the
first 2 weeks post injury (PaO2/FiO2) among patients with no
bacterial pathogens isolated from respiratory secretions
during the first 2 weeks (NEG), patients with bacterial
pathogens of any type (POS), and patients with gram negative
bacteria (GN POS). Patients in whom no bacterial cultures were
collected are not included in this analysis. * = P,.05 vs. NEG.
doi:10.1371/journal.pone.0064250.g002
Table 2. Microbiologic data of positive respiratory samples collected from subjects in the first 14 days according to gram stain.
Gram positive organisms Gram negative organisms
ORSA, OSSA, Streptococcal pneumoniae, diptheroids Haemophilus influenzae, Enterobacter aerogenes, Moraxella catarrhalis, Acinetobacter
baumannii, klebsiella pneumoniae, Escherichia coli
doi:10.1371/journal.pone.0064250.t002
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relationship between IL-8 levels and reduction of risk for ARDS,
but no temporal changes in IL-10 or relation to lung injury risk
during this early time period. Davis et al. [21] found that mortality
was associated with immune hyporesponsiveness manifested by
generally lower cytokine levels of immunomodulators, e.g., IL-1b,
IL-8, and IL-10, in BALF obtained within the first14 hrs after
injury, and decreased release of cytokines by BALF leukocytes in
short-term culture ex vivo. Our measured cytokine concentrations
were higher (Table 2) than those reported by Davis et al., probably
due to less dilution of airway secretions in our bronchial washings,
compared to BALF. In an separate report from the same cohort,
elevated cytokine levels were associated with more severe
bronchoscopic grades of inhalation injury, with the exception of
IL-12, which was reduced compared to control subjects [22],
which are consistent with our findings that showed lower levels of
IL-12p70 in association with more severe lung injury.
Despite many studies, there is still a lack of reliable prognostic
markers of ALI. Some of the inflammatory mediators that have
been examined with respect to ALI include: IL-1b, TNF-a, IL-8,
ICAM-8, plasminogen activator inhibitor-1, Protein C, IL-10/
TNF-a ratio, and IL-6. Serum and BALF levels of IL-1b have
been observed to strongly correlate with poor outcome and
severity of lung injury [19], but require careful study due to the
complexity of the IL-1b inhibitory system also present in these
fluids. Recent studies by others have demonstrated IL-1b and
other inflammasome-mediated cytokines may serve as a novel
biomarker for ALI [23]. This requires further study, as we have
shown that inflammasome related genes are rapidly down
regulated after burn injury [24]. TNF-a has also been studied
and correlates well with severity of ALI, but is complicated to
measure and correlate with ALI as increased inhibitory soluble
TNF-a receptors also need to be measured in parallel. IL-6 is
produced in response to inflammation and has been implicated in
the progression to ALI and cardiovascular disease [25]. Even with
these studies, a specific subset of these indices in combination has
been suggested as having the best predictive value [26]. IL-8 and
SP-D are the best performing combination when predicting
clinical outcome. Interestingly, this study did not include IL-10
within their tested group of biologic markers. Increased levels of
lung IL-10 have been described in experimental animal models for
acute lung injury due to lung contusion and aspiration [27], and
alcohol plus burn exposure [28]. Elevated plasma IL-10 and
several other mediators were recently reported to be markers for
progression to ALI in patients after traumatic injuries [29].
Relative quantities of cytokines present in the airways early after
injury may help direct immune and inflammatory responses
toward an injurious rather than a reparative response, perhaps via
effects on macrophage differentiation and downstream cytokine
patterns [30]. Wu et al. [31] reported increased endogenous IL-10
levels in the lungs of mice after LPS-induced acute lung injury.
Administration of exogenous IL-10 appeared to have a protective
effect. This suggests that IL-10 may be beneficial, rather than
deleterious, with respect to acute lung injury, under some
circumstances. A recent report of markedly suppressed cytokine
Table 3. Mediator concentrations in mainstem bronchial
washings, averaged for samples obtained during the first
72 hr post injury.
PaO2/FiO2 .200 PaO2/FiO2 ,200
N 24 16
IL-1b (pg/ml) 11756516 309161761
IL-6 (pg/ml) 17476945 23896797
IL-8 (pg/ml) 23,51569277 27,39367737
IL-10 (pg/ml) 35.264.7 87.1618.6
IL-12p70 (pg/ml) 20.162.2 16.562.8
TNF-a (pg/ml) 229.2670.5 10466310.6
TGF-b1 (pg/ml) 245.3660.0 371.36157.6
IFNc (pg/ml) 81.2611.3 102.1620.5
CGRP (ng/ml) 0.460.1 4.563.6
dsDNA (ng/ml) 24856619 604961416
Data are shown as mean 6 SE.
doi:10.1371/journal.pone.0064250.t003
Figure 3. Comparison of averaged early (,72 hr post injury) IL-
10 concentrations in mainstem bronchial washings, between
the lowest PaO2/FiO2 ratios ratios during the first 2 weeks post
injury (PaO2/FiO2) of ,200 (N = 16), and patients with PaO2/
FiO2 $200 (N = 24). Bars represent mean 6 SE. * P,0.05, t-test with
Welch’s correction for unequal variances.
doi:10.1371/journal.pone.0064250.g003
Figure 4. Comparison of averaged early (,72 hr post injury) IL-
12p70 concentrations in mainstem bronchial washings, be-
tween the lowest PaO2/FiO2 ratios during the first 2 weeks post
injury (PaO2/FiO2) of ,200 (N = 16), and patients with PaO2/
FiO2 $200 (N = 24). Bars represent mean 6 SE.
doi:10.1371/journal.pone.0064250.g004
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secretion by splenocytes recovered at autopsy from patients dying
of sepsis, compared to patients recovering, supports the impor-
tance of cytokine patterns in predicting clinical outcomes of
critically ill patients [32].
While it did not reach statistical significance, we also observed
elevated DNA concentrations in bronchial washings, on average,
in patients with lower PaO2/FiO2 ratios. Potential sources of DNA
in airway secretions include directly damaged epithelial cells and
inflammatory cells (e.g., neutrophils) responding to injury
[2,33,34]. Our data cannot differentiate among these cellular
sources, since all the factors that we measured could be derived
from multiple cell types. Whatever its source, it is possible that
DNA may function as an endogenous damage-associated molec-
ular pattern (DAMP) after inhalational injury, for example driving
the inflammatory component of ALI via interactions with TLR9
on neutrophils [35,36].
Experimental animal model data and clinical experience have
linked bacterial infection to poor outcomes in burn/inhalational
injury, particularly with gram-negative pathogens such as Pseudo-
monas [37,38]. Our data also suggest a potential relationship
between gram-negative bacteria in the respiratory tract and ALI
(Fig. 2). However, our observational study design in which cultures
were not uniformly or systematically collected does not allow
strong conclusions about this relationship. While associations
between bacterial infection and risk for ALI in the burn/
inhalational injury setting are not surprising, our data justify
inclusion of infection as a potential confounder in the multivariate
model exploring the roles of specific host defense factors in
development of ALI.
Our study has several limitations. Since we relied on clinically
indicated procedures and samples in a critically ill population,
both our patient population and our sample collection frequency
were variable. Therapy was individualized as well, which means
that there were multiple interventions (e.g., fluid resuscitation,
antibiotics) occurring which could have affected the data we
measured. Even under the strictest of protocols, studies involving
the analysis of bronchial lavages have the potential to introduce
variability in sample collection due to the dilution of native
secretions with exogenous lavage fluid and incomplete retrieval of
infused lavage fluid. This variability is difficult to accurately
account for amongst patient samples. In this regard, the use of
cytokine ratios (Fig. 5), while biologically artificial, may be a more
reliable indicator of data comparisons between groups, since
dilution factors drop out of the analysis.
For our analysis, we used the lowest PaO2/FiO2 ratio at any
time during the first 14 days after injury, as our primary outcome
of lung injury, and we presented our data for descriptive purposes
comparing patients with a ratio of ,200, indicating more severe
lung injury, to those with ratios .200, indicating less severe lung
injury. The majority of our patients also had radiographic
abnormalities (Table 1), however, the relationship of these
abnormalities to the degree of severity of lung injury make
interpretation problematic. Thus, we did not attempt to sort
patients based on the complete clinical definition of ARDS
[39,40], which also includes chest x-ray and left atrial pressure
parameters.
Despite these limitations, we believe this study represents a
novel and useful approach for translational research into
pulmonary complications after inhalational injury. While our data
do not suggest specific treatments, understanding this biology is
essential for developing interventions to minimize respiratory tract
morbidity and mortality in these patients. Our observations
support testable hypotheses regarding the pathophysiology of ALI
and gram-negative infection following inhalation of soot by
persons injured in fires. For example, a hypothesis consistent with
our results is that initial airway injury increases levels of airway IL-
10, which if prolonged, results in immune suppression and
increased risk for gram-negative infection. In parallel, dsDNA in
the airways may function as a damage-associated molecular
pattern (DAMP), mediating early innate immune activation that
contributes to development of lung injury. Persistent exposure to
this DAMP could contribute to suppression of TLR and
inflammasome dependent innate immune processes, also leading
to increased risk of gram-negative infection. Mechanistic studies
using experimental models will be required to test these
hypotheses. Additionally, continued investigation of factors that
modify airway cell responses to soot will likely identify other
mechanisms which contribute to both the severity of lung injury
and risk of airway infection.
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